FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy Test Cyp/Prop/Deca-Nan 125mg/Ml Recall

TEST CYP/PROP/DECA-NAN 125MG/ML (80/10/10) IN SESAME OIL, Rx only, Red Mountain Compoun…

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy · Mesa, AZ

Risk level
Class II
Reported by FDA
Nov 3, 2021
Recall ID
D-0048-2022
Check your lot numberHow we source this data

Summary

First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy recalled Test Cyp/Prop/Deca-Nan 125mg/Ml starting Aug 13, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0048-2022 on Nov 3, 2021. Reason: Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns

Product description

TEST CYP/PROP/DECA-NAN 125MG/ML (80/10/10) IN SESAME OIL, Rx only, Red Mountain Compounding Rx

Lot numbers, UPCs & expiration codes

all lots within expiry

Where it was sold

494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0048-2022
Classification
Class II
Status
Terminated
Recall initiated
Aug 13, 2021
FDA report date
Nov 3, 2021
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy

Original FDA data

Every field from FDA enforcement report D-0048-2022, exactly as published.

Show all FDA fields
City
Mesa
State
AZ
Status
Terminated
Country
United States
Event ID
88693
Address
6828 E Brown Rd Ste 101
Code information
all lots within expiry
Postal code
85207-3761
Report date
Nov 3, 2021
Product type
Drugs
Recall number
D-0048-2022
Classification
Class II
Recalling firm
First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy
Termination date
Apr 12, 2023
Reason for recall
Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns
Voluntary / mandated
Voluntary: Firm initiated
Product description
TEST CYP/PROP/DECA-NAN 125MG/ML (80/10/10) IN SESAME OIL, Rx only, Red Mountain Compounding Rx
Distribution pattern
494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.
Recall initiation date
Aug 13, 2021
Center classification date
Oct 26, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0048-2022, published Nov 3, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls